Medical oncologist Kenneth Yu spoke about a study he led that suggests that a simple blood test may be able to predict which chemotherapy regimen will work for some patients with pancreatic cancer.
Claudia Ayash, co-director of Memorial Sloan-Kettering’s Arab American Breast Cancer Education and Referral Program, spoke about the breast cancer screening obstacles some Arab American women face.
Biostatistician Colin Begg commented on a study that found that newer and more expensive breast cancer screening methods may not benefit women over age 65.
Director of Memorial Sloan-Kettering’s Center for Health Policy and OutcomesPeter Bach commented on a study that found that medical school debt may influence the type of medicine young doctors go on to practice.
Surgical oncologist Sam Yoon spoke about a rare genetic mutation that increases the likelihood of developing gastric cancer and the prophylactic surgery some patients are opting to receive to reduce their chances of developing the disease.
Victor Ribaudo, Executive Director of Memorial Sloan-Kettering’s Regional Care Network, commented on the construction progress of Memorial Sloan-Kettering’s newest regional center set to open in Harrison, New York, in 2015.
Medical oncologist Leonard Saltz commented on Memorial Sloan-Kettering’s decision not to carry a new colorectal cancer drug due to its cost and the rising costs of cancer care.
Cell researcher Michel Sadelain commented on an experimental treatment in which the body’s own immune cells are reprogrammed to target and attack leukemia.
Surgical oncologist Monica Morrow discussed a study she led that looked at whether preoperative MRIs may do more harm than good for women facing breast cancer surgery.
